Klinikum Bayreuth

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Acute lymphoblastic leukaemia1 trial
• Alzheimer disease1 trial
• Chronic myeloid leukaemia1 trial
• Colorectal cancer1 trial
• Gastric and oesophageal cancer1 trial
• Liver and biliary tract cancer1 trial
• Metastatic breast cancer1 trial
• Pancreatic cancer1 trial
• Peripheral artery disease1 trial
• Vascular dementia1 trial

Phase

• Phase 22 trials

Status

• Recruiting3 trials
• Active, not recruiting2 trials
• Completed2 trials

Lead sponsor

• Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest2 trials
• Biotronik AG1 trial
• European LeukemiaNet1 trial
• Goethe University1 trial
• University Hospital Tuebingen1 trial
• and 1 more

Running trials

• Active, not recruiting

  BIOTRONIK Dynetic-35 Stent for the Treatment of Peripheral Iliac Lesions

  NCT04830228· Biotronik AG· Source

• Recruiting

  Digital Dementia Registry Bavaria (digiDEM Bayern): a Multicentre, Prospective, Longitudinal Register Study Including People With Mild Cognitive Impairment and Dementia as Well as Their Family Caregivers

  NCT07721701· University of Erlangen-Nürnberg Medical School· Source

  Contact: Thomas Tümena

• Active, not recruiting

  2nd or 3rd TKI-stop After 2 Years Nilotinib Pre-treatment in CML-patients

  NCT02917720· Phase 2· European LeukemiaNet· Source

• Recruiting

  Praegnant Breast Cancer: Early/Advanced/Metastatic

  NCT02338167· University Hospital Tuebingen· Source

  Contact: Erik Belleville, PhD

• Recruiting

  GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial

  NCT02872987· Goethe University· Source

  Contact: Nicola Gökbuget, Dr. med.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute lymphoblastic leukaemia1 recruiting
• Alzheimer disease1 recruiting
• Metastatic breast cancer1 recruiting
• Vascular dementia1 recruiting

Closed trials

• Completed

  PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)

  NCT04484636· Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest· Source

• Completed

  Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Met. Colorectal Cancer

  NCT03530267· Phase 2· Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest· Source